A single dose of meningococcal vaccine ACWY (ie, Menactra or Menveo) vaccine at age 11 through 12 years, with a booster dose at age 16 years, is recommended for routine vaccination. Meningococcal vaccination with conjugate ACWY vaccine is indicated in high-risk children as early as age 6 weeks with anatomic or functional asplenia or persistent complement component deficiencies, or in those who are traveling to or residing in countries in which meningococcal disease is hyperendemic or endemic. If the first dose of meningococcal vaccine is administered at age 13-15 years, a booster dose is indicated at age 16-18 years, with a minimum of 8 weeks between doses. Meningitis B vaccines (ie, Trumenba or Bexsero) are not recommended as routine vaccines. They may be indicated for high-risk children (ie, asplenia or complement deficiencies) beginning at age 10 years. The meningitis B vaccines are not interchangeable; the same product must be used for each dose.
For more on meningitis, read here.
Medscape © 2016 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L. Windle. Fast Five Quiz: Do You Know Current Vaccination Recommendations? - Medscape - Aug 22, 2016.
Comments